ClosetInvestor, CytoDyn Reaches Enrollment of 1
Post# of 145836
![Avatar](/images/ProfileImages/119774003_44865_IHub Pic.jpg)
CytoDyn Reaches Enrollment of 195 Patients in its Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms: Aug 25, 2020
220 patients @ September 30.
So 25 patients in app. 35 days. Enrollment must speed up and that is what we were told will happen in conference.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)